"Cyclosporine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).
Descriptor ID |
D016572
|
MeSH Number(s) |
D04.345.566.235.300 D12.644.641.235.300
|
Concept/Terms |
Cyclosporine- Cyclosporine
- Cyclosporin
- Cyclosporine A
- Ciclosporin
- Cyclosporin A
|
Below are MeSH descriptors whose meaning is more general than "Cyclosporine".
Below are MeSH descriptors whose meaning is more specific than "Cyclosporine".
This graph shows the total number of publications written about "Cyclosporine" by people in this website by year, and whether "Cyclosporine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 2 | 4 |
1995 | 5 | 6 | 11 |
1996 | 2 | 3 | 5 |
1997 | 4 | 3 | 7 |
1998 | 6 | 3 | 9 |
1999 | 4 | 4 | 8 |
2000 | 2 | 8 | 10 |
2001 | 5 | 5 | 10 |
2002 | 4 | 5 | 9 |
2003 | 3 | 12 | 15 |
2004 | 3 | 8 | 11 |
2005 | 5 | 2 | 7 |
2006 | 3 | 2 | 5 |
2007 | 1 | 3 | 4 |
2008 | 5 | 5 | 10 |
2009 | 7 | 2 | 9 |
2010 | 2 | 6 | 8 |
2011 | 1 | 3 | 4 |
2012 | 1 | 1 | 2 |
2013 | 1 | 2 | 3 |
2014 | 2 | 4 | 6 |
2015 | 5 | 4 | 9 |
2016 | 0 | 3 | 3 |
2017 | 2 | 5 | 7 |
2018 | 0 | 1 | 1 |
2019 | 6 | 0 | 6 |
2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclosporine" by people in Profiles.
-
Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies. Int J Nanomedicine. 2024; 19:1163-1187.
-
Calcineurin Inhibitor Voclosporin Preserves Corneal Barrier and Conjunctival Goblet Cells in Experimental Dry Eye. J Ocul Pharmacol Ther. 2020 11; 36(9):679-685.
-
A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. Sci Adv. 2020 06; 6(24):eabb3900.
-
Topical cyclosporine A therapy for dry eye syndrome. Cochrane Database Syst Rev. 2019 09 13; 9:CD010051.
-
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes. PLoS One. 2019; 14(7):e0218709.
-
Intra-Arrest Administration of Cyclosporine and Methylprednisolone Does Not Reduce Postarrest Myocardial Dysfunction. Biomed Res Int. 2019; 2019:6539050.
-
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 09; 25(9):1744-1755.
-
First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome. BMC Psychiatry. 2019 04 24; 19(1):123.
-
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study. Haematologica. 2019 10; 104(10):1974-1983.
-
What is causing this patient's multiple skin abscesses? JAAPA. 2018 Nov; 31(11):54-55.